Results 201 to 210 of about 242,673 (264)

On an Erdős similarity problem in the large

Bulletin of the London Mathematical Society, EarlyView.
Abstract In a recent paper, Kolountzakis and Papageorgiou ask if for every ε∈(0,1]$\epsilon \in (0,1]$, there exists a set S⊆R$S \subseteq \mathbb {R}$ such that |S∩I|⩾1−ε$\vert S \cap I\vert \geqslant 1 - \epsilon$ for every interval I⊂R$I \subset \mathbb {R}$ with unit length, but that does not contain any affine copy of a given increasing sequence ...
Xiang Gao, Yuveshen Mooroogen, Chi Hoi Yip   +2 more
wiley   +1 more source

Factor Xa inhibitors versus low-molecular-weight heparin for preventing coagulopathy following COVID-19: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Amin L, Qayyum K, Uzair M, Khan F, Sethi P, Hanif L, Azhar A, Mazhar S, Ejaz U, Jawad S.   +9 more
europepmc   +1 more source

Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors. [PDF]

TH Open
Goldin M, Smith K, Koulas I, Leung T, Ravi M, Parhar S, Shah S, Floyd K, Ohanesian L, Bain R, Defonte D, Ochani K, Lin A, Patel B, Tsaftaridis N, Jnani J, Spyropoulos AC.   +16 more
europepmc   +1 more source

Comparison of Fixed Versus Weight-Based Prothrombin Complex Concentrate Dosing Strategies for Factor Xa Inhibitor Reversal. [PDF]

Clin Appl Thromb Hemost
Brett S, Taylor M, Pamela M, Michael G.
europepmc   +1 more source

Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies. [PDF]

J Clin Med
Ferreira LO, Oldemburg RAL, Leitão Filho JM, Cerveira RA, Vasconcelos VW, da Costa GE, Rodrigues RDR, Lopes DCF.   +7 more
europepmc   +1 more source

Inhibitors of Factor Xa [PDF]

, 1999
Thrombin occupies a central position in thrombus formation and recently has been a target for the development of anticoagulant agents. As is well known, blood coagulation operates as a cascade or multiple enzymatic amplification process. In the classical intrinsic pathway, factor (f) IXa in the presence of fVIIIa, Ca2+ and phospholipid converts fX to ...
S. Kunitada, T. Hara, T. Nagahara
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Factor Xa inhibitors

Expert Opinion on Therapeutic Patents, 1999
The invention provides compounds which specifically inhibit factor Xa activity. The compounds consist of the structure X1 -YIR-X2, wherein X1 is H, acyl, alkyl, acylalkyl, arylalkyl or one or more amino acids, and X2 is a modified C-terminal group, one or more carboxy-protecting groups or one or more amino acids or other substituent, and Y, I and R are
Pavel Safar, Peter Strop, Alena Stierandova, Fahad Al-Obeidi, Michal Lebl, James A. Ostrem, Armin Walser   +6 more
openaire   +2 more sources